-transparent.png){kind=logo}
Acquired erythrocyte pyruvate kinase deficiency may appear as a symptom secondary to various hematologic disorders, e.g. acute leukemia, sideroblastic anemia, polycythemia vera. The case of a 68-year-old patient with PK deficiency (1.75 U/g Hb) and severe hemolytic anemia is presented, who 1 year later showed acute myeloid leukemia. It is considered that a dialysable inhibiting factor may play a pathogenetic role in this enzyme change since enzyme activity was raised by dialysis. A survey of the literature is presented.
Related Publications
V Helmstädter, and
H Arnold, and
K G Blume, and
N Uhl, and
W Hunstein
April 1986,
Archives of internal medicine,
V Helmstädter, and
H Arnold, and
K G Blume, and
N Uhl, and
W Hunstein
January 1977,
Annals of clinical and laboratory science,
V Helmstädter, and
H Arnold, and
K G Blume, and
N Uhl, and
W Hunstein
October 1978,
Haematologica,
V Helmstädter, and
H Arnold, and
K G Blume, and
N Uhl, and
W Hunstein
August 1979,
Clinica chimica acta; international journal of clinical chemistry,
V Helmstädter, and
H Arnold, and
K G Blume, and
N Uhl, and
W Hunstein
August 1978,
American journal of clinical pathology,
V Helmstädter, and
H Arnold, and
K G Blume, and
N Uhl, and
W Hunstein
January 1968,
Acta haematologica,
V Helmstädter, and
H Arnold, and
K G Blume, and
N Uhl, and
W Hunstein
January 1975,
Enzyme,
V Helmstädter, and
H Arnold, and
K G Blume, and
N Uhl, and
W Hunstein
September 1992,
BMJ (Clinical research ed.),
V Helmstädter, and
H Arnold, and
K G Blume, and
N Uhl, and
W Hunstein
April 1990,
Clinical biochemistry,
V Helmstädter, and
H Arnold, and
K G Blume, and
N Uhl, and
W Hunstein
January 1990,
Progress in clinical and biological research,
